Skip to content
Home/Companies/MedTech/Methys Dx

Methys Dx

MedTech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Methys Dx?

Methys Dx is a French MedTech company, currently owned by Erganeo since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Erganeo
Investor
Erganeo
Erganeo · 2012 · VC

Key facts

HQFrance
SectorMedTech

More from Erganeo

Other portfolio companies in the same fund.

Greennovation
Active
France· 2025
Lafame
Active
France· 2025
PegmaTiss BioTech
Active
HealthcareFrance· 2023
Izonics
Active
IndustrialsFrance· 2022
Persea
Active
BiotechFrance· 2022
AbilyCare
Active
HealthTechFrance· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Methys Dx?

Methys Dx is currently owned by Erganeo, through Erganeo, since 2021.

When did Erganeo acquire Methys Dx?

Erganeo acquired Methys Dx in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue